Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.

Brainerd CJ, Reyna VF, Petersen RC, Smith GE, Kenney AE, Gross CJ, Taub ES, Plassman BL, Fisher GG.

Neuropsychology. 2013 Jan;27(1):86-94. doi: 10.1037/a0030855.

2.

Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.

Brainerd CJ, Reyna VF, Petersen RC, Smith GE, Taub ES.

Neuropsychology. 2011 Nov;25(6):679-89. doi: 10.1037/a0024483.

PMID:
21728427
4.

Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.

Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV.

Bipolar Disord. 2016 Feb;18(1):71-7. doi: 10.1111/bdi.12367. Epub 2016 Feb 15.

PMID:
26877211
5.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
6.

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

PMID:
25162367
7.

Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.

Elcoroaristizabal Martín X, Fernández Martínez M, Galdos Alcelay L, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Gómez Busto F, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MA, de Pancorbo MM.

Dement Geriatr Cogn Disord. 2011;32(5):332-41. doi: 10.1159/000335541. Epub 2012 Feb 3.

PMID:
22311091
8.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
9.

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.

Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D; AIBL Research Group.

Brain. 2013 Jul;136(Pt 7):2201-16. doi: 10.1093/brain/awt127. Epub 2013 Jun 3.

PMID:
23737466
10.

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555. Epub 2011 Apr 14.

PMID:
21493755
11.

Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M.

J Alzheimers Dis. 2014;41(3):739-48. doi: 10.3233/JAD-132516.

12.

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C; Alzheimer's Neuroimaging Initiative.

Neuroimage Clin. 2013 Nov 28;4:164-73. doi: 10.1016/j.nicl.2013.11.010. eCollection 2014.

13.

Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, Bondi MW.

J Alzheimers Dis. 2012;31 Suppl 3:S59-74.

14.

Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.

Viticchi G, Falsetti L, Vernieri F, Altamura C, Altavilla R, Luzzi S, Bartolini M, Provinciali L, Silvestrini M.

J Alzheimers Dis. 2014;41(2):401-10. doi: 10.3233/JAD-132480.

PMID:
24625799
15.

Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.

Lanni C, Garbin G, Lisa A, Biundo F, Ranzenigo A, Sinforiani E, Cuzzoni G, Govoni S, Ranzani GN, Racchi M.

J Alzheimers Dis. 2012;32(4):919-26. doi: 10.3233/JAD-2012-120358.

PMID:
22890094
16.

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.

Neurocase. 2005 Feb;11(1):3-7.

PMID:
15804918
17.

Apolipoprotein ε4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies.

Fei M, Jianhua W.

J Mol Neurosci. 2013 Jun;50(2):257-63. doi: 10.1007/s12031-012-9934-y. Epub 2012 Dec 15.

PMID:
23242623
18.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
19.

Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.

Beydoun MA, Beydoun HA, Kaufman JS, An Y, Resnick SM, O'Brien R, Ferrucci L, Zonderman AB.

J Am Geriatr Soc. 2013 Apr;61(4):525-34. doi: 10.1111/jgs.12156. Epub 2013 Mar 21.

20.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11.

Supplemental Content

Support Center